Teva Latest To Recall Valsartan-Containing Hypertension Drug
Mealey's (December 4, 2018, 3:14 PM EST) -- SILVER SPRING, Md. — Teva Pharmaceuticals on Nov. 27 became the eighth drug company to voluntarily recall valsartan-containing drugs because of the presence of N-nitrosodimethylamine (NDMA), a possible human carcinogen, the...
To view the full article, register now.
Try for FREE for fourteen days
Already a subscriber? Click here to login